Infectious Diseases 1705 - Infectious Disease Alert - May 01, 2013

Target Audience:

This activity is intended for the infectious disease specialist.


Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing:

Stan Deresinski, MD, FACP, FIDSA
Clinical Professor of Medicine
Stanford University
Hospital Epidemiologist
Sequoia Hospital
Redwood City, CA

Board Member and Updates Author
Carol A. Kemper, MD, FACP
Section Editor Updates
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center

Board Member and Peer Reviewer
Timothy Jenkins, MD
Assistant Professor of Medicine
University of Colorado
Denver Health Medical Center

Board Member and Associate Editor
Richard R. Watkins, MD, MS, FACP
Division of Infectious Diseases
Akron General Medical Center
Akron, OH
Associate Professor of Internal Medicine,
Northeast Ohio Medical University
Rootstown, OH

Dean L. Winslow, MD, FACP, FIDSA
Chairman, Department of Medicine
Santa Clara Valley, Medical Center
Clinical Professor
Stanford University School of Medicine


  • Avian H7N9 Flu Emerging in China, U.S. Cases May Be Recent Travelers
  • Infections may Play a Role in Cognitive Decline, Dementia
  • Coccidioidomycosis'” a Growth Industry
  • Illness in Returned Travelers 2007-2011
  • Is it Q Fever? High Index of Suspicion may be Needed
  • Ampicillin plus Ceftriaxone for Enterococcal Endocarditis
  • Crossing the border with highly resistant TB
  • Fecal Transplant Centers are growing in'˜poopularity'
  • Bedbug Detection Squad


  • discuss the diagnosis and treatment of infectious diseases
  • explain current data regarding the use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • discuss the latest information regarding risks, benefits and cost-effectiveness of new and traditional diagnostic tests
  • discuss new information regarding how infectious diseases are transmitted and how such information can lead to the development of new therapies

Financial Disclosure:

Infectious Disease Alert's Editor, Stan Deresinski, MD, FACP, FIDSA, does research for the National Institutes of Health, and is an advisory board member and consultant for Merck. Updates Author Carol A. Kemper, MD, FACP, does research for Abbott Laboratories, and Merck. Peer Reviewer Timothy Jenkins, MD, and Associate Editor Richard R. Watkins, MD, MS, FACP report no financial relationship relevant to this field of study.

Associate Editor Dean L. Winslow, MD, FACP, FIDSA is a consultant for Siemens Diagnostic..

Copyright 2013 AHC Media. All rights reserved.